banner

Products

Poct Multi

Poct Multi

INTENDED USE The Multi-drug test is rapid chromatographic immunoassays for the qualitative and simultaneous detection of
SHARE

Description

Basic Info.
Model NO. MD
Storage 2~30 º C
Specimen Urine
Component Rapid Test Cup of Dipstick Card
Transport Package 25tests/Box; 40tests/Box
Specification 1000tests/carton
Trademark Dewei
Origin China
Product Description

INTENDED USE

The Multi-drug test is rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

ParameterCalibrator
THC11-nor-D9-THC-9-COOH
COCBenzoylecgonine
PCPPhencyclidine
OPIMorphine
METMethamphetamine
MTDMethadone
AMPAmphetamine
BARSecobarbital
BZOOxazepam
TCANortriptyline
MDMA3,4-Methylenediioxy-MET
BUPBUP-3-D-Glucuronide
BUPBUP-3-D-Glucuronide
EDDPEDDP
OPI/MOPMorphine
KETKetamine
TRATramadol
FYLFentanyl
COTCotinine

For other drugs, you can send mail or call us.PRINCIPLERapid Multi-Drug Test is a competitive immunoassay that is used to screen for the presence of various drugs and drug metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites. When the test is activated, the urine is absorbed into each test strip by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test strip. This produces a colored Test line in the Test Region (T) of the strip, which, regardless of its intensity, indicates a negative test result.When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.To serve as a procedure control, a colored line will appear at the Control Region (C), of each strip, if the test has been performed properly.STORAGEThe kit should be stored at 2-30°C until the expiry date printed on the sealed pouch.The test must remain in the sealed pouch until use.Keep away from direct sunlight, moisture and heat.Do not freeze.Care should be taken to protect the components of the kit from contamination. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results. OPERATIONAllow the test device, specimen, buffer, and/or controls to equilibrate to room temperature (15-30°C) prior to testing.

PRODUCT IMAGES

R&D TEAMPRODUCTION LINECERTIFICATESEXHIBITIONS SHIPMENTS

Our Contact